-
Company Profile
Clarus Therapeutics Holdings Inc – Company Profile
Clarus Therapeutics Holdings Inc (Clarus Therapeutics) is a pharmaceutical company that develops and markets oral drugs for the treatment of testosterone deficiency and hypogonadism. The company develops JATENZO, a proprietary softgel capsule that contains a testosterone (T) prodrug and T undecanoate formulated to foster absorption via the intestinal lymphatic system. Its oral product eliminates the risk of T transfer to women and children associated with the T gels. The company also develops T replacement therapies. It partners with pharmaceutical companies...
Add to Basket -
Product Insights
Net Present Value Model: Jatenzo
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Jatenzo Drug Details Testosterone undecanoate (Jatenzo)...
-
Product Insights
Secondary (Hypogonadotropic) Hypogonadism Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Secondary (Hypogonadotropic) Hypogonadism Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Secondary (Hypogonadotropic) Hypogonadism Clinical trials scenario. This report provides top line data relating to the clinical trials on Secondary (Hypogonadotropic) Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor...
-
Product Insights
Secondary (Hypogonadotropic) Hypogonadism Disease – Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Secondary (Hypogonadotropic) Hypogonadism Global Clinical Trials Review, H1, 2020" provides an overview of Secondary (Hypogonadotropic) Hypogonadism Clinical trials scenario. This report provides top line data relating to the clinical trials on Secondary (Hypogonadotropic) Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
United States Dental Devices Market Outlook to 2025 – CAD/CAM Systems and Materials, Dental Bone Graft Substitutes & Regenerative Materials, Dental Equipment and Others
“What is covered in the report about the “United States Dental Devices Market”? GlobalData’s “United States Dental Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the United States Dental Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – CAD/CAM Systems and Materials, Dental Bone Graft Substitutes & Regenerative Materials, Dental Equipment, Dental Hygiene Devices, Dental Imaging, Dental Implants & Abutments, Dental Lasers, Dental...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H1, 2018" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Male Hypogonadism Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Male Hypogonadism Global Clinical Trials Review, H2, 2017" provides an overview of Male Hypogonadism clinical trials scenario. This report provides top line data relating to the clinical trials on Male Hypogonadism. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...